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Abstract: Many pathological conditions lead to altered intracellular pH (pHi ) disrupting normal
cellular functions. The chemical exchange saturation transfer (CEST) method, known as Amine
and Amide Concentration Independent Detection (AACID), can produce image contrast that is
predominantly dependent on tissue intracellular pHi . The AACID value is linearly related to the
ratio of the 3.5 ppm amide CEST effect and the 2.75 ppm amine CEST effect in the physiological
range. However, the amine CEST effect at 2 ppm is often more clearly defined in vivo, and may
provide greater sensitivity to pH changes. The purpose of the current study was to compare AACID
measurement precision utilizing the 2.0 and 2.75 ppm amine CEST effects. We hypothesized that
the 2.0 ppm amine CEST resonance would produce measurements with greater sensitivity to pH
changes. In the current study, we compare the range of the AACID values obtained in 24 mice with
brain tumors and in normal tissue using the 2 ppm and 2.75 ppm amine resonances. All CEST data
were acquired on a 9.4T MRI scanner. The AACID measurement range increased by 39% when
using the 2 ppm amine resonance compared to the 2.75 ppm resonance, with decreased measurement
variability across the brain. These data indicate that in vivo pH measurements made using AACID
CEST can be enhanced by incorporating the 2 ppm amine resonance. This approach should be
considered for pH measurements made over short intervals when no changes are expected in the
concentration of metabolites that contribute to the 2 ppm amine resonance.
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1. Introduction
Intracellular pH plays an important role in many physiological processes, including
apoptosis, cell proliferation, and protein interactions, and it is altered in several disease
states. In cancer, altered intracellular and extracellular pH gradients can lead to drug
resistance [1,2]. Chemical exchange saturation transfer (CEST) can produce image contrast
that is dependent on tissue pH [3–6], and can be used to non-invasively study cellular pH
under various conditions. More specifically, amide proton transfer (APT) efficiency varies
with pH, providing sensitivity to this physiological parameter. Although the measurement
of the APT CEST effect depends on several factors including the amide proton concentration, water concentration, and the relaxivity (R1 ) of bulk water [6], this contrast has been
successfully used to identify ischemic tissue following acute stroke [7–12] and to study
cancer [13–17].
In previous work [18] using 9.4T MRI, we have demonstrated that the ratio of the
3.5 ppm amide CEST effect to the 2.75 ppm amine CEST effect varies linearly with pH
in the physiological range, and is largely independent of protein concentration and temperature [18]. This ratiometric CEST method called Amine and Amide Concentration

Tomography 2022, 8, 730–739. https://doi.org/10.3390/tomography8020060

https://www.mdpi.com/journal/tomography

Tomography 2022, 8

731

Independent Detection (AACID) [18] is sensitive to the acidification of the brain following
stroke, and to the increased intracellular pH in brain tumors [19,20]. The method has also
been used to measure the magnitude of acute tumor acidification using the pharmacologic
agents lonidamine, topiramate, dichloroacetate, cariporide, and quercetin [19–23].
However, due to the fast exchange rate of amine protons in vivo, the 2.75 amine CEST
effect provides only a small response to changes in pH when using the low amplitude, long
duration saturation schemes typically used for amide proton detection. In contrast, the
2.0 ppm amine peak is better defined and produces a greater in vivo pH response [24,25].
The CEST effect at 2.0 ppm is largely associated with creatine [24,25] and guanidinium [26],
and has been shown to correlate with the creatine concentration measured by 1 H-MRS [25].
A recent study demonstrated that reduced creatine CEST measured at 2 ppm could help
differentiate aggressive from non-aggressive gliomas [26]. Given that the 2.0 ppm amine
peak is more easily detected in vivo, the use of this peak could increase the sensitivity
of short-interval in vivo AACID ratiometric measurements compared to the use of the
2.75 ppm amine peak, particularly for the rapid measurement of pH changes after administration of pharmacologic agents, where short term changes in creatine and guanidinium
are not expected.
The purpose of the current study was to investigate whether AACID CEST measurements incorporating the 2 ppm amine resonance would have greater sensitivity compared
to measurements made using the 2.75 ppm resonance in brain tumors and contralateral
tissue. Protamine phantoms were first used to determine whether there was a linear relationship between the AACID value measured using the 2.0 ppm amine resonance and
pH within the physiological pH range, followed by a re-examination of AACID CEST data
previously acquired in mice with brain tumors.
2. Experimental
2.1. Phantom Preparation
To validate the use of the 2 ppm amine resonance in the calculation of the AACID ratio,
we examined whether the AACID response was linear over the physiological pH range.
A series of protamine (EMD Millipore, Oakville, ON, Canada) phantoms were created in
5 mm diameter tubes with pH values ranging from 6–8: 6.12, 6.32, 6.56, 6.78, 7.12, 7.44, 7.71,
and 8.03. Protamine produces a 2 ppm amine CEST peak analogous to that observed in the
human brain [27,28]. The phantoms contained protamine at a concentration of 12 mg/mL
dissolved in phosphate buffered saline. All phantoms were scanned simultaneously at
37 ◦ C.
To characterize the magnitude of the CEST effect at 2 ppm as a function of creatine
concentration at constant pH, a series of creatine (Sigma Aldrich, Oakville, ON, Canada)
and bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA) phantoms were
used. These phantoms were created in 5 mm diameter tubes with creatine concentrations
ranging from 0–20 mM, mixed in 10% bovine serum albumin (BSA) at pH 7. Creatine
contributes to the 2 ppm amine CEST peak observed in vivo [24,25]. All phantoms were
scanned simultaneously at 37 ◦ C.
2.2. Animal Tumor Preparation
All data utilized in this work were obtained from previous studies where animal
procedures were approved by the Animal Care Committee at Western University. The
animal GBM model used in these studies was previously described [19,21–23] but is provided here for completeness. GBM brain tumors were induced in all twenty-four (N = 24),
Crl:Nu-Foxn1Nu (NU/NU) mice (22–27 g, Charles River Laboratories, Saint-Constant, QC,
Canada) included in this study. Briefly, U87MG glioma cells established from a human
GBM (ATCC; Rockville, MD, USA) [29] were grown at 37 ◦ C using Dulbecco’s modified
Eagles’ medium supplemented with 10% fetal bovine serum (Wisent Inc., St-Jean-Baptiste,
QC, Canada). Cells were grown in a humidified incubator with 5% CO2 and passaged twice
a week. The U87MG cells were washed and dissociated with versene solution (PBS plus
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0.5 mM EDTA). The cells were then washed twice with PBS, counted, and re-suspended to
produce a final concentration of 1 × 105 cells in 2 mL PBS prior to injection. The mice were
anesthetized using 4% inhaled isoflurane and then maintained under anesthesia using 1.5%
isoflurane. A stereotactic head frame (Stoelting instruments, Wood Dale, IL, USA) was
used to guide cell injection. After exposing the bregma, a 1 mm diameter hole was drilled
1 mm anterior and 2 mm lateral to the bregma. A Hamilton syringe (Reno, NV, USA) with
a 27-gauge needle attached was used to inject 2 µL of U87MG cells 3 mm deep from the
bregma at a rate of 0.5 µL/min, into the right frontal lobe [19,21–23].
2.3. Preparation of Mice for In Vivo Imaging
CEST data from all mice included in this study have been previously used to produce AACID maps using the 2.75 ppm resonance [19,21–23]. In the current study, we
re-examined the data from these mice to compare the AACID CEST measurements using
the 2.0 ppm and 2.75 ppm amine resonances. The imaging protocol that was used is summarized as follows. The mouse head was placed within a 30 mm millipede volume coil in
a dedicated small animal MRI scanner (9.4T, Agilent, Palo Alto, CA, USA) approximately
fifteen (15 ± 1) days after the injection of cancer cell. Mice were anesthetized initially
using 4% inhaled isoflurane in oxygen and then maintained using 1.5%–2.5% isoflurane
in oxygen. A custom-built MRI-compatible stage was used to secure each mouse, and
a bite bar was used to further reduce motion in the head [20]. Respiratory motion was
also reduced using surgical tape. A rectal temperature probe was used to monitor temperature, and a respiratory sensor pad connected to a pressure transducer placed on the
thoracic region was used to monitor breathing. Warm air blown over the animal using
a model 1025 small-animal monitoring and gating system (SA Instruments Inc., Stony
Brook, NY, USA) maintained body temperature between 36.9–37.1 ◦ C during imaging.
Animals were sacrificed immediately after MR imaging. Data from a single (NU/NU)
mouse (Charles River Laboratories, Saint-Constant, QC, Canada) without tumor was also
included for comparison.
2.4. Magnetic Resonance Imaging
All phantoms (protamine and creatine phantoms) were scanned using the same 30 mm
millipede volume coil used to scan the mice. This study reanalyzed the in vivo data from
previously published studies that used the following imaging protocol [19,21,22]. T2 weighted images were acquired to visualize the phantoms or the tumor in mice using a
fast spin-echo pulse sequence (FSE) with the following parameters: slice thickness = 1 mm,
matrix size = 128 × 128, FOV = 25.6 × 25.6 mm2 , ETL = 4, effective TE = 40 ms, and
TR/TE = 3000/10 ms. These T2 -weighted images were used to position the CEST slab
(4 mm thickness) for maximum phantom or tumor coverage. An FSE pulse sequence
preceded by a continuous wave radiofrequency (RF) pulse (1.5 µT amplitude and 4 s
duration) was used to acquire CEST images (slice thickness = 4 mm, matrix size = 64 × 64,
FOV = 25.6 × 25.6 mm2 , ETL = 32, effective TE = 7 ms, TR = 7000). A series of 49 CEST
images was acquired at sampling saturation frequencies from 1.2 to 4.5 (∆ = 0.1) ppm,
from 5.4 to 6.6 (∆ = 0.1) ppm, and at −1000 and 1000 ppm as references. Two series of
CEST images were acquired to increase the signal-to-noise ratio. The water saturation shift
referencing (WASSR) technique was used for correction of the B0 shifts [30]. A series of
37 WASSR CEST images were acquired with saturation frequencies linearly spaced between
−0.6−0.6 ppm. The same pulse sequence as the AACID CEST acquisition was used for
WASSR, except it was preceded by a low amplitude (0.2 µT) short duration (100 ms) RF
saturation pulse.
2.5. CEST Data Processing
Custom MATLAB (Mathworks, Natick, MA, USA) code was used to analyze all CEST
data on a pixel-by-pixel basis as previously described [19,21–23]. The WASSR and CEST
spectra associated with each pixel were interpolated to 1-Hz resolution. The “smooth”
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algorithm in the MATLAB curve fitting toolbox was used to smooth all the CEST spectra.
To correct the shifts induced by B0 field variations within the sample, the CEST spectrum
was frequency shifted for each pixel so that the water signal was centered at 0 ppm, using
the corresponding WASSR spectrum. This correction ensured that B0 variations were
corrected prior to summing the spectra from pixels within defined regions of interest. After
the B0 corrections, the CEST spectra from both acquisitions were added to increase the
signal-to-noise ratio. No B1 correction was applied [19] because we have previously shown
that the B1 variation in the CEST slice was not appreciable [19].
2.5.1. Calculation of AACID Values
The ratio of the CEST effects at 2.75 ppm (amine protons) and at 3.50 ppm (amide
protons), normalized by the CEST effect at 6.0 ppm, gives the AACID2.75 value, as shown
in Equation (1) [18].

MZ3.5 ppm × MZ6.0 ppm − MZ2.75 ppm

AACID2.75 =
(1)
MZ2.75 ppm × MZ6.0 ppm − MZ3.5 ppm
The AACID2.0 value (Equation (2)) was calculated by substituting the CEST effect at
2.0 ppm for the CEST effect at 2.75 ppm in Equation (1).

MZ3.5 ppm × MZ6.0 ppm − MZ2.0 ppm

AACID2.0 =
(2)
MZ2.0 ppm × MZ6.0 ppm − MZ3.5 ppm
The mouse brain AACID2.0 maps were normalized to the average AACID2.0 value
measured in the contralateral ROIs of all 24 mice. The same approach was used to normalize
the mouse brain AACID2.75 maps using the average AACID2.75 value. This approach
simplified the visual assessment of the quantitative AACID maps.
2.5.2. Statistical Analysis
Contralateral tissue and tumor tissue regions of interest (ROIs) were manually drawn
in each mouse brain by M.A., guided by the T2 -weighted images. The ROIs were drawn
using the MATLAB “roipoly” function and the average AACID values within each ROI
were calculated. A paired Student’s t-test was used to identify differences in average
AACID values between the U87MG tumors and the contralateral tissue in the 24 mice when
using the 2.75 ppm and 2.0 ppm amine resonances (GraphPad Prism Version 9.3.1.471 for
Windows, GraphPad Software, San Diego, CA, USA). In all comparisons, p < 0.05 was
considered statistically significant.
3. Results
A sample image of the arrangement of the protamine phantoms in the MRI scanner is
provided in (Figure 1a). In the protamine solutions, the AACID2.0 value calculated using
Equation (2) varied nonlinearly as a function of pH (Figure 1b) over the large range of pH
values tested, showing greater pH sensitivity at a low pH (below 6.6) and little sensitivity
above pH 7.4. The pH response in the range from pH 6.6–7.4 could be approximated as a
linear function (indicated by the superimposed line).
The creatine CEST effect was concentration-dependent and easily detected when using
the 1.5 µT and 4 s duration saturation pulse used in the AACID acquisition scheme. The
CEST peak observed at 2 ppm showed a greater CEST effect as the creatine concentration
increased (Figure 2a). Consequently, the AACID values increase linearly as expected as the
creatine concentration increased (Figure 2b).
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Figure 1. (a) T2-weighted FSE image showing cross sections of eight protamine samples at pH values
ranging from 6.12 to 8.03 in NMR tubes scanned at 9.4T and at 37 °C. (b) AACID values calculated
using the 2 ppm amine resonance as a function of pH in protamine samples. The relationship between AACID and pH can be approximated as linear between pH 6.6–7.4. The AACID value is most
sensitive to change at low pH (6.1–6.6) and does not change appreciably above pH 7.4. Error bars
represent the standard error of the mean within each NMR tube.
Figure 1. (a) T -weighted FSE image showing cross sections of eight protamine samples at pH values
Figure 1. (a) T22-weighted FSE image showing cross sections of eight protamine samples at pH values
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The creatine CEST effect was concentration-dependent and easily detected when using the 1.5 µT and 4 s duration saturation pulse used in the AACID acquisition scheme.
The CEST peak observed at 2 ppm showed a greater CEST effect as the creatine concentration increased (Figure 2a). Consequently, the AACID values increase linearly as expected as the creatine concentration increased (Figure 2b).
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The average AACID2.75 value in U87MG tumors was 1.15 ± 0.05, while the average
AACID2.75 value in contralateral tissue was 1.27 ± 0.041. The average AACID2.0 value in
U87MG tumors was 1.93 ± 0.11 while the average AACID2.0 value in contralateral tissue
was 2.12 ± 0.10. In both cases, the AACID value in the tumor was significantly lower (p <
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4. Discussion

The objective of this work was to determine whether the use of the 2 ppm amine
resonance could increase the sensitivity of the AACID ratiometric measurement of intracellular pH. In protamine phantoms, it was shown that the AACID2.0 value obtained using
the 2 ppm resonance could be approximated by a linear function between pH 6.6 and 7.4
at 37 °C. Comparing the in vivo AACID2.0 measurements in tumor and in contralateral
tissue to the AACID2.75 measurements, the 2 ppm amine resonance increased the AACID
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4. Discussion
The objective of this work was to determine whether the use of the 2 ppm amine resonance could increase the sensitivity of the AACID ratiometric measurement of intracellular
pH. In protamine phantoms, it was shown that the AACID2.0 value obtained using the
2 ppm resonance could be approximated by a linear function between pH 6.6 and 7.4 at
37 ◦ C. Comparing the in vivo AACID2.0 measurements in tumor and in contralateral tissue
to the AACID2.75 measurements, the 2 ppm amine resonance increased the AACID range by
39% compared to the 2.75 ppm resonance. This greater range suggests that using the 2 ppm
amine resonance could improve AACID-based pH measurement in vivo. The main drawback of using the 2 ppm amine resonance is that it includes contributions from metabolites
such as creatine (guanidinium protons), which can fluctuate in concentration in different
tissue types. Therefore, the 2 ppm amine resonance should only be used in conditions
where creatine concentration can be approximated as stable throughout the measurement.
Protamine is a small, arginine-rich protein that was used in the current study to
model CEST contrast because it contains both exchangeable amine and amide protons
that can be used in the AACID measurement. The protamine CEST spectra showed the
expected peaks at 2.0 ppm from amine protons and at 3.5 ppm from amide protons. The
approximately linear relationship observed between the AACID2.0 value and pH in the
protamine phantoms within the physiological pH range (6.6–7.4) is not required, but ensures
that changes in the AACID value can be easily related to changes in pH. Such a linear
response was previously shown for the AACID value obtained when using the 2.75 ppm
amine resonance in bovine serum albumin [18]. The previously observed pHi dependent
contrast was also insensitive to macromolecule concentration, tissue temperature, and bulk
water T1 relaxation [18]. In vivo, the 2 ppm resonance is mostly produced by creatine,
although there are also contributions from other metabolites that have chemical shifts near
2 ppm, such as phosphocreatine, adenosine triphosphate, guanidinium and adenosine
diphosphate. However, these metabolites have a slower amine proton exchange rate at
physiological pH compared to creatine [31]. Therefore, the in vivo 2 ppm CEST signal can
be mostly attributed to creatine [26,31,32].
To estimate the absolute pH change indicated by a change to the AACID2.0 measurement, the AACID2.0 values can be calibrated using the literature values of pH in tumors
and healthy tissue. For example, the average AACID2.0 measurement in tumors from all
24 mice can be equated to 7.3, the average pH previously measured in brain tumors [33–38].
Similarly, the average AACID2.0 measurement on the contralateral side can be equated to
7.0, the average pH previously found in normal brain tissue [33–38]. Since AACID2.0 is
linearly-dependent on pHi over this narrow range (Figure 1b), this approach to calibration
can be used to estimate the absolute pH change in healthy tissue or a tumor following an
intervention. However, as described above, the 2 ppm CEST signal is also dependent on
creatine concentration [26,31]. Creatine concentration is known to be different in cancerous
tissue and to change with tumor progression. Specifically, glioma had significantly lower Cr
CEST, a feature that could help to differentiate gliomas with different aggressiveness [26].
Moreover, creatine concentration depends on the tissue cell type and cellular composition.
Therefore, to avoid potential errors caused by differences in the tissue Cr concentration,
the use of AACID-based pH measurement in vivo with the 2 ppm amine resonance is best
suited only to measure the change in pH after drug treatments. The 2 ppm resonance should
not be used to compare tissues or in conditions that could potentially involve changes in
Cr concentration associated with disease progression [25,26].
Several limitations must be considered in this study. First, the scope of testing was
limited to only one tumor model (U87 glioma). It is expected that different tumor types
will produce different changes in the AACID measurement, potentially due to a different
concentration of creatine within the tumors. Future studies that incorporate regional
1 H magnetic resonance spectroscopy measurements of creatine within the tumors could
be used to assess the dependency of the 2 ppm AACID CEST measurement on creatine
concentrations. Similarly, our in vitro work was limited to protamine. Other protein
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solutions containing a different ratio of amine to amide group concentrations would be
expected to show a different response of the AACID value to pH.
5. Conclusions
AACID measurements sensitive to tissue intracellular pH can be made with the
2.75 ppm or 2.0 ppm amine resonance. Use of the 2 ppm amine resonance can provide a
greater measurement range compared to the 2.75 ppm amine resonance. However, this
method includes contributions from metabolites such as creatine that can fluctuate in
concentration in different tissue types. Therefore, use of the 2 ppm amine resonance can
be advantageous, but it should be considered only when measuring pH changes under
conditions where the metabolites that contribute to the 2 ppm amine signal are stable for
the duration of the measurement.
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